Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis-Reference-Cited by-同舟云学术

Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

Published:2015-07-22 Issue:6 Volume:42 Page:685-695
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ashida K.¹,Sakurai Y.²,Nishimura A.²,Kudou K.²,Hiramatsu N.³,Umegaki E.⁴,Iwakiri K.⁵,Chiba T.⁶

Affiliation:

1. Rakuwakai Otowa Hospital; Kyoto Japan

2. Takeda Pharmaceutical Company Ltd.; Osaka Japan

3. Osaka University Graduate School of Medicine; Osaka Japan

4. Kobe University Graduate School of Medicine; Kobe Japan

5. Nippon Medical School Graduate School of Medicine; Tokyo Japan

6. Graduate School of Medicine and Faculty of Medicine; Kyoto University; Kyoto Japan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13331/fullpdf

Reference33 articles.

1. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis;Chiba;Gastroenterology,1997

2. Short-term treatment of gastroesophageal reflux disease;Pinxteren;J Gen Intern Med,2003

3. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials;Edwards;Aliment Pharmacol Ther,2009

4. Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis;Fennerty;Aliment Pharmacol Ther,2005

5. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety;Vakil;Aliment Pharmacol Ther,2001

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

2. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

3. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials;Biological and Pharmaceutical Bulletin;2024-08-01

4. Treatment Response With Potassium-competitive Acid Blockers Based on Clinical Phenotypes of Gastroesophageal Reflux Disease: A Systematic Literature Review and Meta-analysis;Journal of Neurogastroenterology and Motility;2024-07-30

5. Efficacy and Safety of Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors in Treating Erosive Esophagitis;Journal of Clinical Gastroenterology;2024-07-30